Recruitment

Recruitment Status
Unknown status

Inclusion Criteria

Discontinuation of any medication with presumed antipruritic effects at least 1 week before the study (including Calmmax cream)
Severity score of pruritus ≥5 as defined by VAS
Negative pregnancy test result for all participating women of childbearing age;
...
Discontinuation of any medication with presumed antipruritic effects at least 1 week before the study (including Calmmax cream)
Severity score of pruritus ≥5 as defined by VAS
Negative pregnancy test result for all participating women of childbearing age;
History of pruritus of >8 weeks duration.

Exclusion Criteria

Known poor adherence to medical recommendations
Active dermatological disorder other than UP
Any acute illness
...
Known poor adherence to medical recommendations
Active dermatological disorder other than UP
Any acute illness
Liver cirrhosis
Inability to give informed consent
Decompensated heart failure
Known allergy to Calmmax cream

Summary

Conditions
Calmmax Cream on UP in CKD Patients.
Type
Interventional
Design
  • Allocation: Randomized
  • Intervention Model: Single Group Assignment
  • Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
  • Primary Purpose: Treatment

Participation Requirements

Age
Between 18 years and 125 years
Gender
Both males and females

Inclusion Criteria

Discontinuation of any medication with presumed antipruritic effects at least 1 week before the study (including Calmmax cream)
Severity score of pruritus ≥5 as defined by VAS
Negative pregnancy test result for all participating women of childbearing age;
...
Discontinuation of any medication with presumed antipruritic effects at least 1 week before the study (including Calmmax cream)
Severity score of pruritus ≥5 as defined by VAS
Negative pregnancy test result for all participating women of childbearing age;
History of pruritus of >8 weeks duration.

Exclusion Criteria

Known poor adherence to medical recommendations
Active dermatological disorder other than UP
Any acute illness
...
Known poor adherence to medical recommendations
Active dermatological disorder other than UP
Any acute illness
Liver cirrhosis
Inability to give informed consent
Decompensated heart failure
Known allergy to Calmmax cream

Tracking Information

NCT #
NCT02032537
Collaborators
Not Provided
Investigators
  • Principal Investigator: Itzchak Slotki, MD Shaare Zedek Medical Center
  • Itzchak Slotki, MD Shaare Zedek Medical Center